KIAA1430_4933411K20Rik inhibitors represent a class of chemicals specifically designed to impede the activity of the KIAA1430_4933411K20Rik protein. This protein, encoded by the 4933411K20Rik gene, plays a pivotal role in a myriad of cellular processes, and its dysfunction can lead to aberrant cellular signaling and physiology. The inhibitors targeting this protein have been developed to intricately bind to or interact with the active sites or crucial regions of the KIAA1430_4933411K20Rik protein, thereby obstructing its function. The action of these inhibitors is not generalized; rather, it is acutely tailored to interfere with the protein's specific activity without altering its expression levels. By doing so, these compounds ensure that the downstream effects of KIAA1430_4933411K20Rik activation are mitigated, leading to a decrease in the protein's functional output.
The molecular architecture of KIAA1430_4933411K20Rik inhibitors allows them to engage in precise inhibitory mechanisms. For instance, some may mimic the substrate or ligand of the KIAA1430_4933411K20Rik protein, competing for binding sites and effectively blocking the protein's natural interactors from exerting their biological effect. Others might allosterically bind to the protein, inducing conformational changes that reduce its activity. The specificity of these interactions is critical, as it ensures that the inhibitors precisely target the KIAA1430_4933411K20Rik protein without influencing unrelated proteins or pathways. This precision not only elucidates the biological functions and importance of KIAA1430_4933411K20Rik but also exemplifies the potential of these compounds to dissect complex signaling networks where this protein is a significant player. The inhibitors, therefore, are invaluable tools for research into the detailed workings of cellular signaling pathways mediated by KIAA1430_4933411K20Rik.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A potent inhibitor of PI3K, which indirectly leads to the inhibition of the Akt signaling pathway. Inhibition of Akt decreases phosphorylation and activation of downstream targets, potentially reducing KIAA1430_4933411K20Rik activity if it's Akt-dependent. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor that can prevent cell growth and proliferation. By inhibiting mTOR, it may indirectly inhibit KIAA1430_4933411K20Rik if it is involved in mTOR signaling pathways. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A p38 MAPK inhibitor that could suppress the MAPK pathway, where inhibition of p38 MAPK could lead to reduced activity of KIAA1430_4933411K20Rik if it is part of this signaling cascade. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
A specific inhibitor of MEK, which could downregulate the ERK pathway, potentially affecting KIAA1430_4933411K20Rik activity if it is regulated by ERK-mediated signaling. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of JNK, which may alter transcription factors and other downstream targets, potentially affecting KIAA1430_4933411K20Rik if its activity is modulated through the JNK signaling pathway. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
A PI3K inhibitor, similar to LY294002, that could also impede the Akt pathway, possibly leading to a reduction in KIAA1430_4933411K20Rik activity if it's Akt-dependent. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
Another MEK inhibitor that could inhibit the ERK pathway, potentially affecting KIAA1430_4933411K20Rik if it relies on ERK signaling for its activation. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
A Src family kinase inhibitor that could disrupt various signaling pathways, including those that may regulate KIAA1430_4933411K20Rik activity if it's associated with Src-mediated signaling. | ||||||
ZM-447439 | 331771-20-1 | sc-200696 sc-200696A | 1 mg 10 mg | $153.00 $356.00 | 15 | |
A selective Aurora kinase inhibitor, which could impact cell cycle progression. If KIAA1430_4933411K20Rik is involved in cell cycle regulation through Aurora kinase, its activity could be diminished by this inhibitor. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
An inhibitor of the TGF-beta receptor, which could affect SMAD signaling and potentially impact KIAA1430_4933411K20Rik if it's involved in TGF-beta receptor pathways. | ||||||